Sumitomo Pharma Co., Ltd. (4506.T)
JPY 575.0
(-0.69%)
JPY 575.0
(-0.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -281.07 Billion JPY | -8946.0% |
| 2022 | -3.49 Billion JPY | -102.81% |
| 2021 | 124.35 Billion JPY | 20.61% |
| 2020 | 103.11 Billion JPY | -1.02% |
| 2019 | 100.28 Billion JPY | 31.48% |
| 2018 | 79.22 Billion JPY | -23.44% |
| 2017 | 95.6 Billion JPY | 40.63% |
| 2016 | 56.18 Billion JPY | 33.54% |
| 2015 | 57.19 Billion JPY | 32.78% |
| 2014 | 42.5 Billion JPY | -39.33% |
| 2013 | 62.49 Billion JPY | 12.78% |
| 2012 | 54.31 Billion JPY | -63.29% |
| 2011 | 57.68 Billion JPY | -5.48% |
| 2010 | 71.59 Billion JPY | 39.86% |
| 2009 | 50.22 Billion JPY | 28.3% |
| 2008 | 43.71 Billion JPY | 88.5% |
| 2007 | 53.45 Billion JPY | -11.73% |
| 2006 | 57.56 Billion JPY | 45.8% |
| 2005 | 40.15 Billion JPY | 99.85% |
| 2004 | 16.98 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.7 Billion JPY | -174.3% |
| 2024 Q1 | 3.8 Billion JPY | 112.63% |
| 2023 Q3 | -21.64 Billion JPY | -46.45% |
| 2023 Q2 | -14.78 Billion JPY | 29.74% |
| 2023 Q1 | -21.03 Billion JPY | 48.0% |
| 2023 Q4 | -221.32 Billion JPY | -922.46% |
| 2023 FY | - JPY | -8946.0% |
| 2022 Q2 | -13.86 Billion JPY | -123.5% |
| 2022 Q1 | 59.01 Billion JPY | 108.53% |
| 2022 Q4 | -40.45 Billion JPY | -293.91% |
| 2022 FY | - JPY | -102.81% |
| 2022 Q3 | 20.86 Billion JPY | 250.48% |
| 2021 Q4 | 28.29 Billion JPY | 4.1% |
| 2021 FY | - JPY | 20.61% |
| 2021 Q1 | 17.18 Billion JPY | 10270.41% |
| 2021 Q2 | 51.69 Billion JPY | 200.73% |
| 2021 Q3 | 27.18 Billion JPY | -47.41% |
| 2020 FY | - JPY | -1.02% |
| 2020 Q1 | 28.32 Billion JPY | 336.76% |
| 2020 Q2 | 29.45 Billion JPY | 3.99% |
| 2020 Q3 | 45.5 Billion JPY | 54.49% |
| 2020 Q4 | -169 Million JPY | -100.37% |
| 2019 FY | - JPY | 31.48% |
| 2019 Q1 | 46.1 Billion JPY | 198.86% |
| 2019 Q2 | 31.63 Billion JPY | -31.39% |
| 2019 Q3 | 18.95 Billion JPY | -40.08% |
| 2019 Q4 | 6.48 Billion JPY | -65.79% |
| 2018 Q1 | 24.19 Billion JPY | -35.91% |
| 2018 FY | - JPY | -23.44% |
| 2018 Q2 | 20.56 Billion JPY | -15.01% |
| 2018 Q3 | 19.04 Billion JPY | -7.37% |
| 2018 Q4 | 15.42 Billion JPY | -19.0% |
| 2017 FY | - JPY | 40.63% |
| 2017 Q4 | 37.75 Billion JPY | 192.5% |
| 2017 Q3 | 12.9 Billion JPY | -62.31% |
| 2017 Q2 | 34.24 Billion JPY | 47.75% |
| 2017 Q1 | 23.17 Billion JPY | 400.24% |
| 2016 Q3 | 26.13 Billion JPY | 406.04% |
| 2016 Q1 | 12.85 Billion JPY | 188.55% |
| 2016 Q4 | 4.63 Billion JPY | -82.27% |
| 2016 FY | - JPY | 33.54% |
| 2016 Q2 | 5.16 Billion JPY | -59.82% |
| 2015 FY | - JPY | 32.78% |
| 2015 Q4 | 4.45 Billion JPY | -67.89% |
| 2015 Q3 | 13.86 Billion JPY | 19.97% |
| 2015 Q2 | 11.56 Billion JPY | 133.11% |
| 2015 Q1 | 4.95 Billion JPY | 12497.5% |
| 2014 Q2 | 2.5 Billion JPY | -74.4% |
| 2014 Q3 | 10.03 Billion JPY | 300.6% |
| 2014 Q4 | -40 Million JPY | -100.4% |
| 2014 FY | - JPY | -39.33% |
| 2014 Q1 | 9.78 Billion JPY | 49.52% |
| 2013 Q3 | 17.17 Billion JPY | 110.18% |
| 2013 FY | - JPY | 12.78% |
| 2013 Q2 | 8.17 Billion JPY | -16.12% |
| 2013 Q1 | 9.74 Billion JPY | 222.23% |
| 2013 Q4 | 6.54 Billion JPY | -61.91% |
| 2012 Q1 | 39.34 Billion JPY | 863.16% |
| 2012 Q2 | 39.53 Billion JPY | 0.47% |
| 2012 Q3 | -45.32 Billion JPY | -214.67% |
| 2012 Q4 | -7.97 Billion JPY | 82.41% |
| 2012 FY | - JPY | -63.29% |
| 2011 Q1 | 44.4 Billion JPY | 135.84% |
| 2011 Q3 | 42.92 Billion JPY | 27.8% |
| 2011 Q4 | 4.08 Billion JPY | -90.48% |
| 2011 FY | - JPY | -5.48% |
| 2011 Q2 | 33.58 Billion JPY | -24.36% |
| 2010 Q4 | 18.82 Billion JPY | -64.09% |
| 2010 FY | - JPY | 39.86% |
| 2010 Q2 | 43.31 Billion JPY | -21.86% |
| 2010 Q1 | 55.43 Billion JPY | 28.76% |
| 2010 Q3 | 52.42 Billion JPY | 21.04% |
| 2009 FY | - JPY | 28.3% |
| 2009 Q4 | 43.04 Billion JPY | 51.68% |
| 2009 Q3 | 28.38 Billion JPY | 20.04% |
| 2009 Q2 | 23.64 Billion JPY | -7.01% |
| 2009 Q1 | 25.42 Billion JPY | 38.03% |
| 2008 Q2 | 20.16 Billion JPY | 0.0% |
| 2008 Q4 | 18.42 Billion JPY | -26.29% |
| 2008 Q3 | 24.99 Billion JPY | 23.93% |
| 2008 FY | - JPY | 88.5% |
| 2007 FY | - JPY | -11.73% |
| 2006 FY | - JPY | 45.8% |
| 2005 FY | - JPY | 99.85% |
| 2004 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.02 Billion JPY | 4768.195% |
| Takeda Pharmaceutical Company Limited | 874.6 Billion JPY | 132.137% |
| Shionogi & Co., Ltd. | 186.7 Billion JPY | 250.546% |
| Wakamoto Pharmaceutical Co.,Ltd. | 570.97 Million JPY | 49326.932% |
| Nippon Shinyaku Co., Ltd. | 36.29 Billion JPY | 874.516% |
| Kaken Pharmaceutical Co., Ltd. | 12.26 Billion JPY | 2391.286% |
| Eisai Co., Ltd. | 103.1 Billion JPY | 372.605% |
| Morishita Jintan Co., Ltd. | 1.29 Billion JPY | 21837.974% |
| Hisamitsu Pharmaceutical Co., Inc. | 18.34 Billion JPY | 1632.563% |
| Mochida Pharmaceutical Co., Ltd. | 8.97 Billion JPY | 3232.419% |
| Fuso Pharmaceutical Industries,Ltd. | 3.67 Billion JPY | 7758.638% |
| Nippon Chemiphar Co., Ltd. | 1.4 Billion JPY | 20133.642% |
| Tsumura & Co. | 30.77 Billion JPY | 1013.402% |
| Kissei Pharmaceutical Co., Ltd. | 18.72 Billion JPY | 1601.453% |
| Torii Pharmaceutical Co., Ltd. | 5.27 Billion JPY | 5432.423% |
| Towa Pharmaceutical Co., Ltd. | 35.53 Billion JPY | 890.95% |
| Fuji Pharma Co., Ltd. | 6.88 Billion JPY | 4184.162% |
| Zeria Pharmaceutical Co., Ltd. | 17.52 Billion JPY | 1704.142% |
| KYORIN Holdings, Inc. | 10.29 Billion JPY | 2829.915% |
| Taiko Pharmaceutical Co.,Ltd. | -3.75 Billion JPY | -7395.253% |
| Daito Pharmaceutical Co.,Ltd. | 7.55 Billion JPY | 3821.329% |
| SymBio Pharmaceuticals Limited | -714 Million JPY | -39265.826% |
| MedRx Co., Ltd | -884.51 Million JPY | -31676.927% |
| Mizuho Medy Co.,Ltd. | 5.53 Billion JPY | 5176.902% |
| Solasia Pharma K.K. | -635 Million JPY | -44163.307% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | -11739.98% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.16 Billion JPY | 3167.467% |
| Sawai Group Holdings Co., Ltd. | 36.87 Billion JPY | 862.27% |
| Cyfuse Biomedical K.K. | -538.28 Million JPY | -52115.817% |
| Toho Holdings Co., Ltd. | 25.84 Billion JPY | 1187.53% |
| Koa Shoji Holdings Co.,Ltd. | 5.1 Billion JPY | 5609.443% |